25-Hydroxy-7-dehydrocholesterol is a sterol derivative and a key intermediate in the biosynthesis of vitamin D. It is structurally related to both 7-dehydrocholesterol (provitamin D3) and 25-hydroxycholecalciferol (calcifediol). This compound serves as a direct precursor to 25-hydroxyvitamin D3 (calcifediol) upon photochemical conversion and subsequent thermal isomerization. Its primary significance lies in the research and development of vitamin D analogs and related endocrine therapies. As a metabolic intermediate, it is crucial for studying the vitamin D metabolic pathway, which is essential for calcium homeostasis and bone health. Consequently, it finds application in the development of drugs targeting endocrine and metabolic disorders, such as osteoporosis, renal osteodystrophy, and certain forms of rickets. This compound is primarily used as a high-value reference standard and a synthetic building block in pharmaceutical research. Handling requires standard precautions for laboratory chemicals, and it should be stored protected from light due to its photosensitive nature.